Chemoinformaics analysis of BETA-CYANOALANINE
| Molecular Weight | 114.104 | nRot | 2 |
| Heavy Atom Molecular Weight | 108.056 | nRig | 2 |
| Exact Molecular Weight | 114.043 | nRing | 0 |
| Solubility: LogS | -0.794 | nHRing | 0 |
| Solubility: LogP | -2.799 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 14.4848 |
| nHD | 2 | BPOL | 6.88724 |
| QED | 0.497 |
| Synth | 3.243 |
| Natural Product Likeliness | 0.472 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.029 |
| HIA | 0.169 |
| CACO-2 | -5.891 |
| MDCK | 0.00361232 |
| BBB | 0.548 |
| PPB | 0.0896008 |
| VDSS | 0.411 |
| FU | 0.884946 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.054 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.043 |
| CYP2c9-inh | 0.009 |
| CYP2c9-sub | 0.215 |
| CYP2d6-inh | 0.038 |
| CYP2d6-sub | 0.131 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.028 |
| CL | 7.265 |
| T12 | 0.827 |
| hERG | 0.011 |
| Ames | 0.042 |
| ROA | 0.133 |
| SkinSen | 0.537 |
| Carcinogencity | 0.454 |
| EI | 0.303 |
| Respiratory | 0.932 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.949983 |